{"id": "article-18793_0", "title": "Canavan Disease -- Continuing Education Activity", "content": "Canavan disease, also called Canavan-Van Bogaert-Bertrand disease, is a rare, progressive, and fatal neurological hereditary disorder that begins in infancy. It is part of a group of genetic diseases referred to as leukodystrophies. It is associated with the deficiency of an essential enzyme resulting in the loss of white matter in the brain, which subsequently leads to the defective transmission of nerve signals. This activity reviews the cause, presentation, pathophysiology and diagnosis of canavan disease and highlights the role of the interprofessional team in its management.", "contents": "Canavan Disease -- Continuing Education Activity. Canavan disease, also called Canavan-Van Bogaert-Bertrand disease, is a rare, progressive, and fatal neurological hereditary disorder that begins in infancy. It is part of a group of genetic diseases referred to as leukodystrophies. It is associated with the deficiency of an essential enzyme resulting in the loss of white matter in the brain, which subsequently leads to the defective transmission of nerve signals. This activity reviews the cause, presentation, pathophysiology and diagnosis of canavan disease and highlights the role of the interprofessional team in its management."}
{"id": "article-18793_1", "title": "Canavan Disease -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of Canavan disease. Review the physical features of a patient with canavan disease. Summarize the treatment options for canavan disease. Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by canavan disease. Access free multiple choice questions on this topic.", "contents": "Canavan Disease -- Continuing Education Activity. Objectives: Describe the pathophysiology of Canavan disease. Review the physical features of a patient with canavan disease. Summarize the treatment options for canavan disease. Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by canavan disease. Access free multiple choice questions on this topic."}
{"id": "article-18793_2", "title": "Canavan Disease -- Introduction", "content": "Canavan disease, also called Canavan-Van Bogaert-Bertrand disease, is a rare, progressive, and fatal neurological hereditary disorder that begins in infancy. It is part of a group of genetic diseases referred to as leukodystrophies. It is associated with the deficiency of an essential enzyme resulting in the loss of white matter in the brain, which subsequently leads to the defective transmission of nerve signals. [1] [2]", "contents": "Canavan Disease -- Introduction. Canavan disease, also called Canavan-Van Bogaert-Bertrand disease, is a rare, progressive, and fatal neurological hereditary disorder that begins in infancy. It is part of a group of genetic diseases referred to as leukodystrophies. It is associated with the deficiency of an essential enzyme resulting in the loss of white matter in the brain, which subsequently leads to the defective transmission of nerve signals. [1] [2]"}
{"id": "article-18793_3", "title": "Canavan Disease -- Introduction", "content": "The neonatal form is the most common and is usually associated with the most severe symptoms. Most infants appear healthy immediately after birth, but within 2 to 6 months, obvious deficits in gross motor development will be apparent. The infant may not be able to move, turn over, control head movements, or support itself. Hypotonia is a common feature and is usually associated with macrocephaly. Most infants have difficulty with feeding and develop seizures. [3] [4]", "contents": "Canavan Disease -- Introduction. The neonatal form is the most common and is usually associated with the most severe symptoms. Most infants appear healthy immediately after birth, but within 2 to 6 months, obvious deficits in gross motor development will be apparent. The infant may not be able to move, turn over, control head movements, or support itself. Hypotonia is a common feature and is usually associated with macrocephaly. Most infants have difficulty with feeding and develop seizures. [3] [4]"}
{"id": "article-18793_4", "title": "Canavan Disease -- Etiology", "content": "Canavan disease is an autosomal recessive disorder associated with a gene locus on chromosome 17. It is caused by a mutation in the ASPA gene that encodes the enzyme aspartoacylase. This mutation results in an aspartoacylase deficiency and the accumulation of N-acetylaspartic acid (NAA) in the brain. NAA is believed to cause oligodendrocyte dysfunction, consequential spongiform changes, and degeneration of myelin in the phospholipid layer of axons. [5]", "contents": "Canavan Disease -- Etiology. Canavan disease is an autosomal recessive disorder associated with a gene locus on chromosome 17. It is caused by a mutation in the ASPA gene that encodes the enzyme aspartoacylase. This mutation results in an aspartoacylase deficiency and the accumulation of N-acetylaspartic acid (NAA) in the brain. NAA is believed to cause oligodendrocyte dysfunction, consequential spongiform changes, and degeneration of myelin in the phospholipid layer of axons. [5]"}
{"id": "article-18793_5", "title": "Canavan Disease -- Epidemiology", "content": "Canavan disease\u00a0is one of the most prevalent degenerative cerebral diseases of infancy.\u00a0It\u00a0frequently affects Ashkenazi Jews but has been described in other populations as well. However, sufficient data is unavailable to calculate the prevalence.\u00a0The carrier frequency among the Ashkenazi varies from 1:37 to 1:57 individuals, yielding approximate prevalence rates ranging from 1:6000 to 1:14,000. [6]", "contents": "Canavan Disease -- Epidemiology. Canavan disease\u00a0is one of the most prevalent degenerative cerebral diseases of infancy.\u00a0It\u00a0frequently affects Ashkenazi Jews but has been described in other populations as well. However, sufficient data is unavailable to calculate the prevalence.\u00a0The carrier frequency among the Ashkenazi varies from 1:37 to 1:57 individuals, yielding approximate prevalence rates ranging from 1:6000 to 1:14,000. [6]"}
{"id": "article-18793_6", "title": "Canavan Disease -- Pathophysiology", "content": "Acetyl-CoA and aspartic acid form\u00a0NAA. It is believed to be the second most common free amino acid in the brain. It is found in neurons, where mitochondria synthesize it and then transfer it to oligodendrocytes through axo-glial contact zones. These axo-glial contact zones are formed between the innermost oligodendrocyte plasma membrane and the axonal membrane.\u00a0NAA is converted to N-acetylaspartylglutamate (NAAG) within neurons. It is subsequently transported to astrocytes, which hydrolyze it to NAA and glutamate. The NAA is then finally taken up by oligodendrocytes which are the primary location of aspartoacylase.", "contents": "Canavan Disease -- Pathophysiology. Acetyl-CoA and aspartic acid form\u00a0NAA. It is believed to be the second most common free amino acid in the brain. It is found in neurons, where mitochondria synthesize it and then transfer it to oligodendrocytes through axo-glial contact zones. These axo-glial contact zones are formed between the innermost oligodendrocyte plasma membrane and the axonal membrane.\u00a0NAA is converted to N-acetylaspartylglutamate (NAAG) within neurons. It is subsequently transported to astrocytes, which hydrolyze it to NAA and glutamate. The NAA is then finally taken up by oligodendrocytes which are the primary location of aspartoacylase."}
{"id": "article-18793_7", "title": "Canavan Disease -- Pathophysiology", "content": "The aspartoacylase enzyme catalyzes the conversion of NAA to aspartate (aspartic acid) and acetate. Therefore, deficiency of this catalyst leads to accumulation of NAA in the brain.\u00a0Levels of NAA are markedly increased in the patient's plasma, urine, and cerebrospinal fluid.\u00a0Abnormal myelination and the associated prominent swollen and vacuolated astrocytes are the fundamental hallmarks of aspartoacylase deficiency. These effects justify the name spongiform leukodystrophy. However, the precise mechanism by which accumulated NAA causes the pathogenesis of this spongiform degeneration remains uncertain.", "contents": "Canavan Disease -- Pathophysiology. The aspartoacylase enzyme catalyzes the conversion of NAA to aspartate (aspartic acid) and acetate. Therefore, deficiency of this catalyst leads to accumulation of NAA in the brain.\u00a0Levels of NAA are markedly increased in the patient's plasma, urine, and cerebrospinal fluid.\u00a0Abnormal myelination and the associated prominent swollen and vacuolated astrocytes are the fundamental hallmarks of aspartoacylase deficiency. These effects justify the name spongiform leukodystrophy. However, the precise mechanism by which accumulated NAA causes the pathogenesis of this spongiform degeneration remains uncertain."}
{"id": "article-18793_8", "title": "Canavan Disease -- History and Physical", "content": "Aspartoacylase deficiency initially presents generally around the age of three months. Typical features include lethargy, listlessness, weak cry and suck, a\u00a0lack of head control when the\u00a0baby is pulled from a lying to a sitting position, hypotonia, poor visual tracking or blindness, vomiting, and seizures. Some authors have also described poor feeding, irritability, and visual inattention.", "contents": "Canavan Disease -- History and Physical. Aspartoacylase deficiency initially presents generally around the age of three months. Typical features include lethargy, listlessness, weak cry and suck, a\u00a0lack of head control when the\u00a0baby is pulled from a lying to a sitting position, hypotonia, poor visual tracking or blindness, vomiting, and seizures. Some authors have also described poor feeding, irritability, and visual inattention."}
{"id": "article-18793_9", "title": "Canavan Disease -- History and Physical", "content": "Macrocephaly, or enlarged head size, becomes prominent by the age of three to six months. After that, hypotonia progresses to spasticity, hyperreflexia, extensor plantar responses, and tonic extensor spasms. The extensor spasms may occur in response to noise. By the age of six months, neurologic irregularities are invariably present with little or no subsequent motor development.", "contents": "Canavan Disease -- History and Physical. Macrocephaly, or enlarged head size, becomes prominent by the age of three to six months. After that, hypotonia progresses to spasticity, hyperreflexia, extensor plantar responses, and tonic extensor spasms. The extensor spasms may occur in response to noise. By the age of six months, neurologic irregularities are invariably present with little or no subsequent motor development."}
{"id": "article-18793_10", "title": "Canavan Disease -- History and Physical", "content": "Blindness due to optic atrophy occurs around the age of 6 to 18 months. Seizures, usually generalized tonic-clonic ones, are noted in about 50% of patients. Unlike most leukodystrophies, the cerebrospinal fluid protein is usually within the reference range. Pseudobulbar signs and decerebrate posturing dominate the end stage of Canavan disease. Feeding is a major issue, with prominent swallowing dysfunction and gastroesophageal reflux.", "contents": "Canavan Disease -- History and Physical. Blindness due to optic atrophy occurs around the age of 6 to 18 months. Seizures, usually generalized tonic-clonic ones, are noted in about 50% of patients. Unlike most leukodystrophies, the cerebrospinal fluid protein is usually within the reference range. Pseudobulbar signs and decerebrate posturing dominate the end stage of Canavan disease. Feeding is a major issue, with prominent swallowing dysfunction and gastroesophageal reflux."}
{"id": "article-18793_11", "title": "Canavan Disease -- History and Physical -- Variant Forms", "content": "The presence of variant forms of aspartoacylase deficiency is controversial. A suggested juvenile-onset form, beginning after age five, is less common. Patients with this form of the disease will have slightly delayed speech and motor skill development since childhood. It is common for such delays to go under-recognized\u00a0due to their mild and nonspecific nature. Onset in adults usually resembles multiple sclerosis on clinical grounds.", "contents": "Canavan Disease -- History and Physical -- Variant Forms. The presence of variant forms of aspartoacylase deficiency is controversial. A suggested juvenile-onset form, beginning after age five, is less common. Patients with this form of the disease will have slightly delayed speech and motor skill development since childhood. It is common for such delays to go under-recognized\u00a0due to their mild and nonspecific nature. Onset in adults usually resembles multiple sclerosis on clinical grounds."}
{"id": "article-18793_12", "title": "Canavan Disease -- Evaluation -- Laboratory Studies", "content": "In symptomatic infants with compatible clinical features and neuroimaging findings suggesting aspartoacylase deficiency, the diagnosis is concluded by observing elevated levels of urine NAA. Compatible clinical features include\u00a0hypotonia, poor head control, and macrocephaly. A determination can be reached\u00a0more specifically by detecting deficient aspartoacylase activity in cultured skin fibroblasts. If elevated urine NAA and skin fibroblast testing are diagnostic, genetic testing is obtained only for genetic counseling. [7] [8] [9] Urine levels of NAA are increased up to 200 times that of the reference range. Gas\u00a0chromatography or mass\u00a0spectrometry are employed for measurement.", "contents": "Canavan Disease -- Evaluation -- Laboratory Studies. In symptomatic infants with compatible clinical features and neuroimaging findings suggesting aspartoacylase deficiency, the diagnosis is concluded by observing elevated levels of urine NAA. Compatible clinical features include\u00a0hypotonia, poor head control, and macrocephaly. A determination can be reached\u00a0more specifically by detecting deficient aspartoacylase activity in cultured skin fibroblasts. If elevated urine NAA and skin fibroblast testing are diagnostic, genetic testing is obtained only for genetic counseling. [7] [8] [9] Urine levels of NAA are increased up to 200 times that of the reference range. Gas\u00a0chromatography or mass\u00a0spectrometry are employed for measurement."}
{"id": "article-18793_13", "title": "Canavan Disease -- Evaluation -- Prenatal Diagnosis", "content": "Prenatal diagnosis is best accomplished by measuring NAA levels in amniotic fluid. This method utilizes a stable isotope dilution coupled with gas\u00a0chromatography or mass\u00a0spectrometry, and also molecular analysis.", "contents": "Canavan Disease -- Evaluation -- Prenatal Diagnosis. Prenatal diagnosis is best accomplished by measuring NAA levels in amniotic fluid. This method utilizes a stable isotope dilution coupled with gas\u00a0chromatography or mass\u00a0spectrometry, and also molecular analysis."}
{"id": "article-18793_14", "title": "Canavan Disease -- Evaluation -- Neuroimaging", "content": "A CT scan shows a\u00a0characteristic low attenuation of white matter in contrast to the relatively unaffected gray matter. This difference is mainly due to spongiform degeneration and edema of the white matter. No post contrast enhancement is usually seen.", "contents": "Canavan Disease -- Evaluation -- Neuroimaging. A CT scan shows a\u00a0characteristic low attenuation of white matter in contrast to the relatively unaffected gray matter. This difference is mainly due to spongiform degeneration and edema of the white matter. No post contrast enhancement is usually seen."}
{"id": "article-18793_15", "title": "Canavan Disease -- Evaluation -- Neuroimaging", "content": "MRI features include a relatively enlarged brain, also called megalencephaly. There is typically a diffuse bilateral white matter involvement. Unlike other leukodystrophies, subcortical U-fibers are usually involved early in the disease process.\u00a0T1 shows\u00a0a low signal in the white matter while\u00a0T2 shows a high signal in white matter. There is no post contrast enhancement.\u00a0MR spectroscopy shows markedly elevated levels of NAA, and an elevated NAA:creatine ratio. The mnemonic \"CaNAAvan\" is useful for remembering this information.", "contents": "Canavan Disease -- Evaluation -- Neuroimaging. MRI features include a relatively enlarged brain, also called megalencephaly. There is typically a diffuse bilateral white matter involvement. Unlike other leukodystrophies, subcortical U-fibers are usually involved early in the disease process.\u00a0T1 shows\u00a0a low signal in the white matter while\u00a0T2 shows a high signal in white matter. There is no post contrast enhancement.\u00a0MR spectroscopy shows markedly elevated levels of NAA, and an elevated NAA:creatine ratio. The mnemonic \"CaNAAvan\" is useful for remembering this information."}
{"id": "article-18793_16", "title": "Canavan Disease -- Treatment / Management", "content": "There is\u00a0no\u00a0currently available disease-modifying therapy for Canavan disease. Management aims to maintain nutrition and hydration, protect\u00a0the airways, prevent seizures, minimize the risk of contractures, and cure infections. An assessment of the patient's nutritional and developmental status is recommended for guiding the management.", "contents": "Canavan Disease -- Treatment / Management. There is\u00a0no\u00a0currently available disease-modifying therapy for Canavan disease. Management aims to maintain nutrition and hydration, protect\u00a0the airways, prevent seizures, minimize the risk of contractures, and cure infections. An assessment of the patient's nutritional and developmental status is recommended for guiding the management."}
{"id": "article-18793_17", "title": "Canavan Disease -- Treatment / Management", "content": "A feeding gastrostomy tube is typically used to maintain adequate nutrition and hydration in the presence of dysphagia. A gastrostomy tube can also decrease the risk of aspiration due to the patient's lack of sound reflexes.", "contents": "Canavan Disease -- Treatment / Management. A feeding gastrostomy tube is typically used to maintain adequate nutrition and hydration in the presence of dysphagia. A gastrostomy tube can also decrease the risk of aspiration due to the patient's lack of sound reflexes."}
{"id": "article-18793_18", "title": "Canavan Disease -- Treatment / Management", "content": "Seizures are managed with standard antiepileptic drugs.\u00a0Physical therapy and position changes are helpful to reduce the risk of contractures and ulcers. They also\u00a0help\u00a0improve\u00a0the\u00a0patient's sitting posture. Botulinum toxin injections can be employed to treat spasticity. Special education programs and interventions can be considered. [10] [11]", "contents": "Canavan Disease -- Treatment / Management. Seizures are managed with standard antiepileptic drugs.\u00a0Physical therapy and position changes are helpful to reduce the risk of contractures and ulcers. They also\u00a0help\u00a0improve\u00a0the\u00a0patient's sitting posture. Botulinum toxin injections can be employed to treat spasticity. Special education programs and interventions can be considered. [10] [11]"}
{"id": "article-18793_19", "title": "Canavan Disease -- Differential Diagnosis", "content": "Consider other dysmyelinating diseases such as: Adrenoleukodystrophy: typically spares subcortical U-fibers, has a characteristic occipitoparietal periventricular white matter distribution Alexander disease: anterior dominance, diffuse late in the disease course, normal NAA on MRS levels Metachromatic leukodystrophy: spares subcortical U-fibers, will have a characteristic 'butterfly' pattern Pelizaeus-Merzbacher disease: associated with cerebellar atrophy, tigroid pattern of hyperintensity, typically spares subcortical U-fibers", "contents": "Canavan Disease -- Differential Diagnosis. Consider other dysmyelinating diseases such as: Adrenoleukodystrophy: typically spares subcortical U-fibers, has a characteristic occipitoparietal periventricular white matter distribution Alexander disease: anterior dominance, diffuse late in the disease course, normal NAA on MRS levels Metachromatic leukodystrophy: spares subcortical U-fibers, will have a characteristic 'butterfly' pattern Pelizaeus-Merzbacher disease: associated with cerebellar atrophy, tigroid pattern of hyperintensity, typically spares subcortical U-fibers"}
{"id": "article-18793_20", "title": "Canavan Disease -- Prognosis", "content": "For severe disease, the prognosis is grave. Survival beyond the first decade of life is not always possible. For mild disease, the life expectancy varies. Most patients make it through puberty and may have an average lifespan.", "contents": "Canavan Disease -- Prognosis. For severe disease, the prognosis is grave. Survival beyond the first decade of life is not always possible. For mild disease, the life expectancy varies. Most patients make it through puberty and may have an average lifespan."}
{"id": "article-18793_21", "title": "Canavan Disease -- Complications", "content": "Intellectual\u00a0disability Lack of motor skills Difficulty feeding Hypotonia Paralysis Blindness Seizures Death", "contents": "Canavan Disease -- Complications. Intellectual\u00a0disability Lack of motor skills Difficulty feeding Hypotonia Paralysis Blindness Seizures Death"}
{"id": "article-18793_22", "title": "Canavan Disease -- Pearls and Other Issues", "content": "Canavan disease\u00a0patients have a variable average lifespan. Most people with the neonatal or infantile form survive only into childhood, although some studies report life expectancy up to adolescence or beyond. People with the mild or juvenile form do not appear to have a shortened lifespan.", "contents": "Canavan Disease -- Pearls and Other Issues. Canavan disease\u00a0patients have a variable average lifespan. Most people with the neonatal or infantile form survive only into childhood, although some studies report life expectancy up to adolescence or beyond. People with the mild or juvenile form do not appear to have a shortened lifespan."}
{"id": "article-18793_23", "title": "Canavan Disease -- Enhancing Healthcare Team Outcomes", "content": "Canavan disease is a rare lethal neurological disorder which is best managed by an interprofessional team that includes a neurologist, internist, geneticist, social worker, nurse, physical therapist, ophthalmologist, and a gastroenterologist. These patients tend to have many physical limitations including an inability to eat, speak or even walk. The prognosis for most patients is poor, even those with mild disease have a poor quality of life. [12]", "contents": "Canavan Disease -- Enhancing Healthcare Team Outcomes. Canavan disease is a rare lethal neurological disorder which is best managed by an interprofessional team that includes a neurologist, internist, geneticist, social worker, nurse, physical therapist, ophthalmologist, and a gastroenterologist. These patients tend to have many physical limitations including an inability to eat, speak or even walk. The prognosis for most patients is poor, even those with mild disease have a poor quality of life. [12]"}
{"id": "article-18793_24", "title": "Canavan Disease -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Canavan Disease -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}